Biomax Biotechnics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-10-2024
- Paid Up Capital ₹ 5.00 M
as on 23-10-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.49 Cr
as on 23-10-2024
- Satisfied Charges ₹ 11.37 Cr
as on 23-10-2024
- Revenue 9.34%
(FY 2023)
- Profit 128.90%
(FY 2023)
- Ebitda 11.84%
(FY 2023)
- Net Worth 23.09%
(FY 2023)
- Total Assets 12.47%
(FY 2023)
About Biomax Biotechnics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹14.49 Cr. The company has closed loans amounting to ₹11.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shobhana and Kamaljit Singh serve as directors at the Company.
- CIN/LLPIN
U24100CH2009PTC031718
- Company No.
031718
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biomax Biotechnics Private Limited offer?
Biomax Biotechnics Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Vitamin Tablets & Capsules, Digestive System Drugs & Medicines, Antacid Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Biomax Biotechnics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamaljit Singh  | Managing Director | 13-Aug-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shobhana | Director | 13-Dec-2012 | Current |
Financial Performance of Biomax Biotechnics.
Biomax Biotechnics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.34% increase. The company also saw a substantial improvement in profitability, with a 128.9% increase in profit. The company's net worth Soared by an impressive increase of 23.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomax Biotechnics?
In 2023, Biomax Biotechnics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Baxton Pharmacia Private LimitedActive 12 years 11 monthsShobhana and Kamaljit Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 14 Sep 2023 | ₹10.79 Cr | Open |
Canara Bank Creation Date: 08 Dec 2022 | ₹3.70 Cr | Open |
Axis Bank Limited Creation Date: 03 Mar 2020 | ₹3.68 M | Satisfied |
How Many Employees Work at Biomax Biotechnics?
Biomax Biotechnics has a workforce of 68 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomax Biotechnics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomax Biotechnics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
